Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Eliem Therapeutics Q2 EPS $(0.56) Up From $(3.11) YoY

Eliem Therapeutics (NASDAQ:ELYM) reported quarterly losses of $(0.56) per share. This is a 81.99 percent increase over losses of $(3.11) per share from the same period last year.
byBenzinga Newsdesk
August 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Eliem Therapeutics (NASDAQ:ELYM) reported quarterly losses of $(0.56) per share. This is a 81.99 percent increase over losses of $(3.11) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts